Literature DB >> 27143416

Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology.

Stephen W Scheff1, Mubeen A Ansari2, Elliott J Mufson3.   

Abstract

Neuritic amyloid plaques and neurofibrillary tangles are hallmarks of Alzheimer's disease (AD) and are major components used for the clinical diagnosis of this disorder. However, many individuals with no cognitive impairment (NCI) also present at autopsy with high levels of these AD pathologic hallmarks. In this study, we evaluated 15 autopsy cases from NCI individuals with high levels of AD-like pathology (high pathology no cognitive impairment) and compared them to age- and postmortem-matched cohorts of individuals with amnestic mild cognitive impairment and NCI cases with low AD-like pathology (low pathology no cognitive impairment [LPNCI]). Individuals classified as high pathology no cognitive impairment or amnestic mild cognitive impairment had a significant loss of both presynaptic and postsynaptic proteins in the hippocampus compared with those in the LPNCI cohort. In addition, these 2 groups had a significant increase in 3 different markers of oxidative stress compared with that in the LPNCI group. The changes in levels of synaptic proteins are strongly associated with levels of oxidative stress. These data suggest that cognitively older subjects without dementia but with increased levels of AD-like pathology may represent a very early preclinical stage of AD.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Amyloid; Dementia; Hippocampus; Neurodegeneration; Synapses; Temporal lobe

Mesh:

Substances:

Year:  2016        PMID: 27143416      PMCID: PMC4857887          DOI: 10.1016/j.neurobiolaging.2016.02.030

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  128 in total

Review 1.  NADPH oxidases: novel therapeutic targets for neurodegenerative diseases.

Authors:  Hui-Ming Gao; Hui Zhou; Jau-Shyong Hong
Journal:  Trends Pharmacol Sci       Date:  2012-04-11       Impact factor: 14.819

2.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

Review 3.  Hippocampal plasticity during the progression of Alzheimer's disease.

Authors:  E J Mufson; L Mahady; D Waters; S E Counts; S E Perez; S T DeKosky; S D Ginsberg; M D Ikonomovic; S W Scheff; L I Binder
Journal:  Neuroscience       Date:  2015-03-12       Impact factor: 3.590

Review 4.  Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).

Authors:  Dennis W Dickson; Naomi Kouri; Melissa E Murray; Keith A Josephs
Journal:  J Mol Neurosci       Date:  2011-07-01       Impact factor: 3.444

5.  University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology.

Authors:  Frederick A Schmitt; Peter T Nelson; Erin Abner; Stephen Scheff; Gregory A Jicha; Charles Smith; Gregory Cooper; Marta Mendiondo; Deborah D Danner; Linda J Van Eldik; Allison Caban-Holt; Mark A Lovell; Richard J Kryscio
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

6.  Protein carbonyl groups as biomarkers of oxidative stress.

Authors:  Isabella Dalle-Donne; Ranieri Rossi; Daniela Giustarini; Aldo Milzani; Roberto Colombo
Journal:  Clin Chim Acta       Date:  2003-03       Impact factor: 3.786

7.  Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

Authors:  Steven T DeKosky; Milos D Ikonomovic; Scot D Styren; Laurel Beckett; Stephen Wisniewski; David A Bennett; Elizabeth J Cochran; Jeffrey H Kordower; Elliott J Mufson
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

8.  Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease.

Authors:  P V Arriagada; K Marzloff; B T Hyman
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

9.  Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.

Authors:  R Katzman; R Terry; R DeTeresa; T Brown; P Davies; P Fuld; X Renbing; A Peck
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

10.  Neuropathology and general autopsy findings in nondemented aged subjects.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  Clin Neuropathol       Date:  2012 Mar-Apr       Impact factor: 1.368

View more
  20 in total

1.  Methionine Sulfoxide Reductase-B3 (MsrB3) Protein Associates with Synaptic Vesicles and its Expression Changes in the Hippocampi of Alzheimer's Disease Patients.

Authors:  Stephanie L Adams; Laurent Benayoun; Kathy Tilton; Olivia R Chavez; Jayandra J Himali; Jan Krzysztof Blusztajn; Sudha Seshadri; Ivana Delalle
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  Alpha-lipoic acid ameliorates tauopathy-induced oxidative stress, apoptosis, and behavioral deficits through the balance of DIAP1/DrICE ratio and redox homeostasis: Age is a determinant factor.

Authors:  Elahe Zarini-Gakiye; Nima Sanadgol; Kazem Parivar; Gholamhassan Vaezi
Journal:  Metab Brain Dis       Date:  2021-02-06       Impact factor: 3.584

Review 3.  Insulin resistance and impaired lipid metabolism as a potential link between diabetes and Alzheimer's disease.

Authors:  Joshua A Kulas; Thaddeus K Weigel; Heather A Ferris
Journal:  Drug Dev Res       Date:  2020-02-05       Impact factor: 4.360

Review 4.  Disordered APP metabolism and neurovasculature in trauma and aging: Combined risks for chronic neurodegenerative disorders.

Authors:  Milos D Ikonomovic; Zhiping Mi; Eric E Abrahamson
Journal:  Ageing Res Rev       Date:  2016-11-06       Impact factor: 10.895

5.  Human LRRK2 G2019S mutation represses post-synaptic protein PSD95 and causes cognitive impairment in transgenic mice.

Authors:  Samuel O Adeosun; Xu Hou; Baoying Zheng; Heather L Melrose; Thomas Mosley; Jun Ming Wang
Journal:  Neurobiol Learn Mem       Date:  2017-05-06       Impact factor: 2.877

Review 6.  Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.

Authors:  D Allan Butterfield; Mark P Mattson
Journal:  Neurobiol Dis       Date:  2020-02-06       Impact factor: 5.996

7.  Loss of precuneus dendritic spines immunopositive for spinophilin is related to cognitive impairment in early Alzheimer's disease.

Authors:  Zhiping Mi; Eric E Abrahamson; Angela Y Ryu; Kenneth N Fish; Robert A Sweet; Elliott J Mufson; Milos D Ikonomovic
Journal:  Neurobiol Aging       Date:  2017-02-04       Impact factor: 4.673

8.  Olfactory Ensheathing Cell-Conditioned Medium Reverts Aβ25-35-Induced Oxidative Damage in SH-SY5Y Cells by Modulating the Mitochondria-Mediated Apoptotic Pathway.

Authors:  Qing-Qing Fu; Li Wei; Javier Sierra; Jian-Zhang Cheng; María Teresa Moreno-Flores; Hua You; Hua-Rong Yu
Journal:  Cell Mol Neurobiol       Date:  2016-11-02       Impact factor: 5.046

9.  Lycopene protects against t-BHP-induced neuronal oxidative damage and apoptosis via activation of the PI3K/Akt pathway.

Authors:  Cuiqin Huang; Caiyan Wen; Mei Yang; Danhui Gan; Chongzhu Fan; An Li; Qin Li; Jiayi Zhao; Lihong Zhu; Daxiang Lu
Journal:  Mol Biol Rep       Date:  2019-04-20       Impact factor: 2.316

10.  Calcineurin proteolysis in astrocytes: Implications for impaired synaptic function.

Authors:  Melanie M Pleiss; Pradoldej Sompol; Susan D Kraner; Hafiz Mohmmad Abdul; Jennifer L Furman; Rodney P Guttmann; Donna M Wilcock; Peter T Nelson; Christopher M Norris
Journal:  Biochim Biophys Acta       Date:  2016-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.